For brokers placing life and living benefits business with ivari, Sagicor Financial Company's second-quarter 2026 results carry three data points worth reading past the headline revenue figure: modest core earnings growth at the Canadian segment, a completed AM Best rating recovery, and a 5% year-over-year decline in new business contractual service margin that signals the underlying sales pipeline warrants monitoring.
Sagicor Financial reported group core earnings to shareholders of US$34.2 million for Q2 2026, down 26% from US$46.0 million a year earlier. Net income to shareholders was US$86.6 million, reversing a US$6.4 million net loss in the same quarter last year - but the reversal reflects favourable equity market and interest rate movements flowing through insurance reserves rather than improved underwriting or new business production. CEO Andre Mousseau said core earnings returned to target levels as insurance experience was broadly in line with expectations, while net income benefited from market movements.
Sagicor Canada's reported revenue jumped to US$828.2 million for the quarter, more than double the US$298.1 million recorded a year earlier. Brokers can set that figure aside. The swing reflects favourable equity market performance flowing through universal life policyholder fund balances, and mark-to-market interest rate movements - both of which show up as revenue under IFRS 17's accounting treatment for these products but do not represent new business or premium growth.
Net premium at Sagicor Canada rose a modest 3% year over year to US$114.7 million. Core earnings to shareholders at the segment grew 8% to US$26.5 million - a genuine improvement. Net income at Sagicor Canada came in at US$70.3 million, well above the US$26.5 million core earnings figure, for the same market-driven reason as the group. For any broker assessing ivari's underlying operating momentum, core earnings rather than net income is the relevant measure.
The number that deserves closest attention is new business contractual service margin. New business CSM - the value placed on new policies written during the quarter at the point of inception, and one of the more direct measures available under IFRS 17 of actual new business productivity - fell 5% year over year at Sagicor Canada to US$10.6 million, even as production held roughly in line with management's expectations. A declining CSM alongside stable volume points to product mix or pricing dynamics compressing the value of business being written. That is worth tracking over coming quarters, not as a concern about ivari's financial stability, but as a signal about sales productivity that has a bearing on compensation and product positioning.
Mousseau's results commentary credited "another strong validation" from a recent AM Best upgrade, framing it specifically around the company's US growth strategy.
That framing is narrower than the upgrade itself. AM Best's July action lifted the financial strength rating to A (Excellent) from A- (Excellent) for four Sagicor subsidiaries together - including ivari directly, not only the US operations. For Canadian brokers and clients holding ivari policies, that detail matters. The upgrade returns ivari's rating to A, completing a multi-year recovery since Sagicor's 2022 acquisition of ivari from Wilton Re, when AM Best had downgraded it to A- and placed it under review pending integration risk. A return to A is the conclusion of that review period, not an incremental improvement on an already stable base.
At the group level, Sagicor's LICAT ratio held at 134% - unchanged from the prior quarter and 34 percentage points above OSFI's 100% supervisory target, indicating a comfortable capital buffer. The financial leverage ratio ticked down slightly to 27.4% and shareholders' equity grew 6% quarter over quarter to US$1.039 billion.
The board declared a quarterly dividend of 7.5 cents per share, consistent with recent quarters, payable in September. Among the four operating segments, Sagicor Jamaica posted the strongest net premium growth at 13% year over year. Sagicor Life USA's net premium fell 1% and core earnings there dropped 64%, which the company attributed to insurance experience losses in its legacy life block - a US-specific issue with no read-across to ivari's book.
None of the quarter's results points to a change in ivari's financial position that a broker needs to act on. Core earnings grew modestly, the AM Best recovery is complete, and capital is stable. The new business CSM figure is the one to watch going forward - not because it signals instability, but because sustained decline in the value of new business written would eventually matter to product economics in ways that would affect brokers placing new business with the carrier.
